Meeder Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-70
| Closed | -$2K | – | 2114 |
|
|
2022
Q3 | $2K | Buy |
70
+6
| +9% | +$171 | ﹤0.01% | 1877 |
|
|
2022
Q2 | $3K | Sell |
64
-13
| -17% | -$609 | ﹤0.01% | 1847 |
|
|
2022
Q1 | $4K | Buy |
+77
| New | +$4K | ﹤0.01% | 1890 |
|
|
2021
Q4 | – | Sell |
-34
| Closed | -$2K | – | 2440 |
|
|
2021
Q3 | $2K | Buy |
34
+17
| +100% | +$1K | ﹤0.01% | 2239 |
|
|
2021
Q2 | $1K | Sell |
17
-14
| -45% | -$824 | ﹤0.01% | 2420 |
|
|
2021
Q1 | $1K | Sell |
31
-21
| -40% | -$677 | ﹤0.01% | 2283 |
|
|
2020
Q4 | $2K | Buy |
52
+10
| +24% | +$385 | ﹤0.01% | 1550 |
|
|
2020
Q3 | $2K | Buy |
42
+34
| +425% | +$1.62K | ﹤0.01% | 1888 |
|
|
2020
Q2 | $0 | Buy |
+8
| New | – | ﹤0.01% | 2554 |
|
|
2020
Q1 | – | Sell |
-741
| Closed | -$44K | – | 2584 |
|
|
2019
Q4 | $44K | Buy |
741
+519
| +234% | +$30.8K | ﹤0.01% | 1060 |
|
|
2019
Q3 | $12K | Buy |
222
+181
| +441% | +$9.78K | ﹤0.01% | 1483 |
|
|
2019
Q2 | $2K | Buy |
+41
| New | +$2K | ﹤0.01% | 1892 |
|
|
2018
Q4 | – | Sell |
-2,097
| Closed | -$146K | – | 1835 |
|
|
2018
Q3 | $146K | Buy |
2,097
+231
| +12% | +$16.1K | 0.01% | 556 |
|
|
2018
Q2 | $141K | Buy |
1,866
+1,305
| +233% | +$98.7K | 0.01% | 566 |
|
|
2018
Q1 | $30K | Buy |
561
+379
| +208% | +$20.3K | ﹤0.01% | 787 |
|
|
2017
Q4 | $9K | Sell |
182
-660
| -78% | -$32.6K | ﹤0.01% | 1167 |
|
|
2017
Q3 | $50K | Buy |
842
+120
| +17% | +$7.13K | 0.01% | 685 |
|
|
2017
Q2 | $57K | Buy |
722
+668
| +1,237% | +$52.7K | 0.01% | 660 |
|
|
2017
Q1 | $4K | Hold |
54
| – | – | ﹤0.01% | 1192 |
|
|
2016
Q4 | $4K | Buy |
+54
| New | +$4K | ﹤0.01% | 886 |
|
|
2016
Q3 | – | Sell |
-1,197
| Closed | -$46K | – | 971 |
|
|
2016
Q2 | $46K | Sell |
1,197
-5,327
| -82% | -$205K | ﹤0.01% | 735 |
|
|
2016
Q1 | $264K | Sell |
6,524
-15,810
| -71% | -$640K | 0.02% | 533 |
|
|
2015
Q4 | $1.98M | Buy |
+22,334
| New | +$1.98M | 0.18% | 136 |
|